Postlung transplant rehospitalization: A study of causes, health care burden, and outcomes

Experimental and Clinical Transplantation

Volumn 7, Issue 3, 2009, Pages 192-196

  Dezfouli, Azizollah Abbasi ^a   Najafizadeh, Katayoun ^a   Parsa, Tahereh ^a   Shadmehr, Mohammad Behgam ^a   Dabir, Shideh ^a   Mohammadi, Foruzan ^a   Tabarsi, Payam ^a   Lankarani, Maryam Moghani ^b   Assari, Shervin ^b   Marjani, Majid ^a   Fahimi, Fanak ^a   Shafaghi, Shadi ^a   Faeghi, Jamileh ^a   Masjedi, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Medicine and Health Promotion Institute   (Iran)

Author keywords

Costs; Health care use; Lung transplant; Rehospitalization; Transplant

Indexed keywords

ACUTE GRAFT REJECTION; ADULT; ARTICLE; FATALITY; GRAFT INFECTION; HEALTH CARE COST; HEALTH CARE PERSONNEL; HOSPITAL COST; HOSPITAL READMISSION; HOSPITALIZATION COST; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG DISEASE; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY;

ADULT; COMMUNICABLE DISEASES; DELIVERY OF HEALTH CARE; DIAGNOSTIC TESTS, ROUTINE; FEMALE; GRAFT REJECTION; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; INTENSIVE CARE; IRAN; LENGTH OF STAY; LUNG TRANSPLANTATION; MALE; MEDICAL STAFF, HOSPITAL; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 75149189607     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Pourfarziani V, Rafati-Shaldehi H, Assari S, et al. Hospitalization databases: a tool for transplantation monitoring. Transplant Proc. 2007;39(4):981-983.
2. Reddy KS, Stablein D, Taranto S, et al. Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure. Am J Kidney Dis. 2003;41(2): 464-470.
3. Abbott KC, Bucci JR, Cruess D, Taylor AJ, Agodoa LY. Graft loss and acute coronary syndromes after renal transplantation in the United States. J Am Soc Nephrol. 2002;13(10):2560-2569.
4. Pourfarziani V, Nourbala MH, Azizabadi Farahani M, Moghani Lankarani M, Assari S. Costs and length of hospitalizations following kidney transplantation. Iran J Kidney Dis. 2009;3(2): 103-108.
5. Nourbala MH, Nemati E, Azizabadi Farahani M, et al. Survival of rehospitalized kidney allograft recipients. Iran J Kidney Dis. 2008;2(4):208-211.
6. Bech B, Pressler T, Iversen M, et al. Long-term outcome of lung transplantation for cystic fibrosis - Danish results. Eur J Cardiothorac Surg. 2004;26(6):1180-1186.
7. Raviv Y, Kramer MR, Amital A, Rubinovitch B, Bishara J, Shitrit D. Outbreak of aspergillosis infections among lung transplant recipients. Transpl Int. 2007;20(2):135-140.
8. Vilchez R, McCurry K, Dauber J, et al. Influenza and parainfluenza respiratory viral infection requiring admission in adult lung transplant recipients. Transplantation. 2002;73(7):1075-1078.
9. Lak M, Jalali AR, Badrkhahan SF, et al. Additional burden of intensive care to rehospitalizations following kidney transplantation: a study of rate, causes, and risk factors. Iran J Kidney Dis. 2008;2(4):212-217.
10. Bonde PN, Patel ND, Borja MC, et al. Impact of donor lung organisms on post-lung transplant pneumonia. J Heart Lung Transplant. 2006;25(1):99-105.
11. Pietrantoni C, Minai OA, Yu NC, et al. Respiratory failure and sepsis are the major causes of ICU admissions and mortality in survivors of lung transplants. Chest. 2003;123(2):504-509.
12. Nielsen TD, Bahnson T, Davis RD, Palmer SM. Atrial fibrillation after pulmonary transplant. Chest. 2004;126(2):496-500.
13. Hadjiliadis D, Steele MP, Govert JA, Davis RD, Palmer SM. Outcome of lung transplant patients admitted to the medical ICU. Chest. 2004;125(3):1040-1045.
14. Massad MG, Kpodonu J, Jaffe HA. ICU admission of the lung transplant recipient following hospital discharge. Chest. 2004;125(3):813-815.
15. Plöchl W, Pezawas L, Artemiou O, Grimm M, Klepetko W, Hiesmayr M. Nutritional status, ICU duration and ICU mortality in lung transplant recipients. Intensive Care Med. 1996;22(11):1179-1185.
16. Najafizadeh K, Ghorbani F, Rostami A, et al. Health status of the patients before lung transplantation: A report from Iran. Ann Transplant. 2009;14(1):5-9.
17. Najafizadeh K, Daneshvar A, Dezfouli AA, et al. Pulmonary artery stenosis shortly after lung transplantation: Successful balloon dilation and stent insertion in one case. Ann Transplant. 2009;14(1):52-55.
18. Najafizadeh K, Ghorbani F, Rostami A, et al. Depression while on the lung transplantation waiting list. Ann Transplant. 2009;14(2):34-37.
19. Abbasi-Dezfouli A, Pojhan S, Behgam-Shadmehr M, et al. The cost of lung transplantation in Iran. Ann Transplant. 2009; 4(2):30-33.
20. Najafizadeh K, Radpei B, Ghorbani F, et al. Our experience with organ procurement from hemodynamically unstable brain dead patients. Ann Transplant. 2009;14(2):20-23.
21. Naderi M, Aslani J, Hashemi M, Assari S, Amini M, Pourfarziani V. Prolonged rehospitalizations following renal transplantation: causes, risk factors, and outcomes. Transplant Proc. 2007;39(4):978-980.
22. Nemati E, Pourfarziani V, Jafari AM, et al. Prediction of inpatient survival and graft loss in rehospitalized kidney recipients. Transplant Proc. 2007;39(4):974-977.
23. Ghoddousi K, Ramezani MK, Assari S, et al. Primary kidney disease and post-renal transplantation hospitalization costs. Transplant Proc. 2007;39(4):962-965.
24. Khedmat H, Araghizadeh H, Assari S, Moghani-Lankarani M, Aghanassir M. Which primary diagnosis has the highest inhospital mortality rate for kidney recipients? Transplant Proc. 2007;39(4):901-903.
25. Arcasoy SM. Medical complications and management of lung transplant recipients. Respir Care Clin N Am. 2004;10(4):505-529.
26. Avery RK. Infections after lung transplantation. Semin Respir Crit Care Med. 2006;27(5):544-551.
27. Czebe K, Antus B, Varga M, Csiszér E. Pulmonary infections after lung transplantation [in Hungarian]. Orv Hetil. 2008;149(3):99-109.
28. Ruiz I, Gavaldà J, Monforte V, et al. Donor-to-host transmission of bacterial and fungal infections in lung transplantation. Am J Transplant. 2006;6(1):178-182.
29. Remund KF, Best M, Egan JJ. Infections relevant to lung transplantation. Proc Am Thorac Soc. 2009;6(1):94-100.
30. Solidoro P, Libertucci D, Delsedime L, et al. Combined cytomegalovirus prophylaxis in lung transplantation: effects on acute rejection, lymphocytic bronchitis/bronchiolitis, and herpesvirus infections. Transplant Proc. 2008;40(6):2013-2014.
31. Schröeder R, Michelon T, Wurdig J, et al. The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir. Braz J Infect Dis. 2007;11(2):212-214.
32. Benden C, Harpur-Sinclair O, Ranasinghe AS, Hartley JC, Elliott MJ, Aurora P. Surveillance bronchoscopy in children during the first year after lung transplantation: Is it worth it? Thorax. 2007;62(1):57-61.
33. Carby M, Jones A, Burke M, Hall A, Banner N. Varicella infection after heart and lung transplantation: a single-center experience. J Heart Lung Transplant. 2007;26(4):399-402.
34. Brumble LM, Milstone AP, Loyd JE, et al. Prevention of cytomegalovirus infection and disease after lung transplantation: results using a unique regimen employing delayed ganciclovir. Chest. 2002;121(2):407-414.
35. Wahidi MM, Willner DA, Snyder LD, Hardison JL, Chia JY, Palmer SM. Diagnosis and outcome of early pleural space infection following lung transplantation. Chest. 2009;135(2):484-491.
36. Husain S, Zaldonis D, Kusne S, Kwak EJ, Paterson DL, McCurry KR. Variation in antifungal prophylaxis strategies in lung transplantation. Transpl Infect Dis. 2006;8(4):213-218.
37. Snell GI, Westall GP. Immunosuppression for lung transplantation: evidence to date. Drugs. 2007;67(11):1531-1539.
38. Knoop C, Haverich A, Fischer S. Immunosuppressive therapy after human lung transplantation. Eur Respir J. 2004;23(1):159-171.
39. Midthun DE, McDougall JC, Peters SG, Scott JP. Medical management and complications in the lung transplant recipient. Mayo Clin Proc. 1997;72(2):175-184.
40. Bravo C, Gispert P, Borro JM, et al. Prevalence and management of gastrointestinal complications in lung transplant patients: MITOS study group. Transplant Proc. 2007;39(7):2409-2412.
41. Hoekstra HJ, Hawkins K, de Boer WJ, Rottier K, van der Bij W. Gastrointestinal complications in lung transplant survivors that require surgical intervention. Br J Surg. 2001;88(3):433-438.
42. Tierce JC, Porterfield-Baxa J, Petrilla AA, Kilburg A, Ferguson RM. Impact of mycophenolate mofetil (MMF)-related gastrointestinal complications and MMF dose alterations on transplant outcomes and healthcare costs in renal transplant recipients. Clin Transplant. 2005;19(6):779-784.
43. Evans RW, Kitzmann DJ. An economic analysis of kidney transplantation. Surg Clin North Am. 1998;78(1):149-174.
44. Khan S, Tighiouart H, Kalra A, Raman G, Rohrer RJ, Pereira BJ. Resource utilization among kidney transplant recipients. Kidney Int. 2003;64(2):657-664.